Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Curaleafs Dr. Mikael Sodergren future of cannabis medicine
View:
Post by blackspade799 on May 12, 2023 10:38am

Curaleafs Dr. Mikael Sodergren future of cannabis medicine

Dr Mikael Sodergren: the future of cannabis medicine in Europe
One of Europe’s leading cannabis researchers on the importance of real-world data in drug development.

One of Europe’s leading cannabis researchers speaks to Cannabis Health about the future of the field and the importance of drawing on patients’ perspectives when it comes to cannabis-based drug development.

https://cannabishealthnews.co.uk/2023/05/12/dr-mikael-sodergren-the-future-of-cannabis-medicine-in-europe/
Comment by TheProphetElijah on May 12, 2023 11:22am
Seems like everytime Safe fails to pass it's another reason for the shorts to attack for another leg down.  I believe yesterdays meeting continues next week.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities